Trial Profile
A Phase I, single-site, randomized, double-blind, double-dummy, parallel-group; thorough QT study of Clobazam in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Oct 2017
Price :
$35
*
At a glance
- Drugs Clobazam (Primary) ; Moxifloxacin
- Indications Dravet syndrome; Lennox-Gastaut syndrome
- Focus Therapeutic Use
- 04 Oct 2017 New trial record
- 25 Sep 2017 Results published in the Clinical Therapeutics